Société Clover Biopharmaceuticals, Ltd.
Actions
2197
KYG2280A1076
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,325 HKD | +3,17 % | -13,33 % | -47,58 % |
Métier
Nombre d'employés: 387
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Joshua Liang
CEO | Chief Executive Officer | - | 25/12/20 |
Aileen Wang
DFI | Director of Finance/CFO | - | 01/03/21 |
Htay Htay Han
CTO | Chief Tech/Sci/R&D Officer | 56 | 03/02/21 |
Wang Xiaoyan
SEC | Corporate Secretary | - | 31/03/23 |
Lily Yang
HRO | Human Resources Officer | - | 01/05/21 |
Liong Ho Chua
PRN | Corporate Officer/Principal | 60 | 27/04/22 |
Xiao Bing Li
PRN | Corporate Officer/Principal | 56 | 27/07/20 |
Hing Ling Chau
SEC | Corporate Secretary | 49 | 22/12/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Jeffrey Farrow
BRD | Director/Board Member | 62 | 19/04/21 |
Xiao Dong Wang
BRD | Director/Board Member | 61 | 16/03/21 |
Xiao Bin Wu
BRD | Director/Board Member | 62 | 19/04/21 |
Donna Ambrosino
BRD | Director/Board Member | 72 | 17/06/22 |
Ralf Clemens
BRD | Director/Board Member | 71 | 17/06/22 |
Thomas Leggett
BRD | Director/Board Member | 47 | 19/04/21 |
Peng Liang
CHM | Chairman | 63 | 31/10/18 |
Joshua Liang
CEO | Chief Executive Officer | - | 25/12/20 |
Xiang Liao
BRD | Director/Board Member | 59 | 19/04/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 1 296 995 429 | 634 599 879 ( 48,93 %) | 0 | 48,93 % |
Coordonnées société
Clover Biopharmaceuticals Ltd.
49F, Park Place 1598-1601 West Nanjing Road
200010, Shanghai
+
http://www.cloverbiopharma.comSecteur
Ventes par région
Chiffre d'affaires trimestriel - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
-47,58 % | 52,17 M | |
-3,14 % | 102 Md | |
+1,52 % | 96,07 Md | |
-1,80 % | 21,66 Md | |
-17,60 % | 20,77 Md | |
-6,91 % | 18,53 Md | |
-42,00 % | 16,91 Md | |
-27,96 % | 13,79 Md | |
-0,02 % | 13,33 Md | |
+19,78 % | 10,94 Md |
- Bourse
- Actions
- Action 2197
- Société Clover Biopharmaceuticals, Ltd.